Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Arvinas Inc (ARVN)

Arvinas Inc (ARVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Arvinas to Participate in Upcoming Investor Conferences GlobeNewswire - Mon Nov 4, 6:00AM CST

ARVN : 25.11 (+10.67%)
Arvinas Reports Third Quarter 2024 Financial Results and Provides Corporate Update GlobeNewswire - Wed Oct 30, 6:00AM CDT

ARVN : 25.11 (+10.67%)
Arvinas Gives Back to Local Greater New Haven Community in Third Annual Impact Day GlobeNewswire - Tue Oct 22, 3:05PM CDT

ARVN : 25.11 (+10.67%)
Arvinas to Report Third Quarter 2024 Financial Results and Provide Corporate Update and Host Webcast on Wednesday, October 30, 2024 GlobeNewswire - Mon Oct 21, 6:00AM CDT

ARVN : 25.11 (+10.67%)
OSI: Fiscal Q4 Earnings Snapshot AP - Thu Aug 22, 8:16AM CDT

OSI: Fiscal Q4 Earnings Snapshot

ARVN : 25.11 (+10.67%)
As Early-Onset Breast Cancer Cases Soar in North America and EU, Biotech Ramps Up Response Newswire.ca - Tue Apr 30, 9:30AM CDT

/CNW/ -- USA News Group – An alarming rise in early-onset cancers has medical experts very concerned, as cancer cases in younger people are rising sharply. In...

ONCY : 0.9800 (-1.85%)
ICCM : 0.5984 (-0.68%)
ATOS : 1.1900 (-0.83%)
ARVN : 25.11 (+10.67%)
PFE : 25.13 (+0.76%)
ONC.TO : 1.37 (-2.14%)
Biotech Firms Intensify Efforts as Breast Cancer Strikes Younger Patients at Alarming Rate BayStreet.ca - Tue Apr 30, 9:04AM CDT

USA News Group – An alarming rise in early-onset cancers has medical experts very concerned, as cancer cases in younger people are rising sharply. In particular, a surge in cases of breast cancer is...

ONCY : 0.9800 (-1.85%)
ONC.TO : 1.37 (-2.14%)
ICCM : 0.5984 (-0.68%)
ATOS : 1.1900 (-0.83%)
ARVN : 25.11 (+10.67%)
PFE : 25.13 (+0.76%)
How Recent Biotech Breakthroughs Are Changing the Fight Against Breast Cancer BayStreet.ca - Wed Feb 7, 8:06AM CST

USA News Group – More people are getting breast cancer this year. Around 300,000 women and 2,800 men will find out they have it. While 1 out of every 8 women will hear they have breast cancer sometime...

ONCY : 0.9800 (-1.85%)
ONC.TO : 1.37 (-2.14%)
PFE : 25.13 (+0.76%)
ARVN : 25.11 (+10.67%)
OLMA : 7.87 (-4.95%)
AZN : 64.26 (+1.68%)
How Recent Biotech Breakthroughs Are Changing the Fight Against Breast Cancer BayStreet.ca - Thu Dec 7, 2023

USA News Group – More people are getting breast cancer this year. Around 300,000 women and 2,800 men will find out they have it. While 1 out of every 8 women will hear they have breast cancer sometime...

AVRN : 0.0125 (-30.56%)
ONCY : 0.9800 (-1.85%)
ONC.TO : 1.37 (-2.14%)
PFE : 25.13 (+0.76%)
ARVN : 25.11 (+10.67%)
OLMA : 7.87 (-4.95%)
AZN : 64.26 (+1.68%)
Arvinas and Quantum Leap Healthcare Announce Clinical Study to Evaluate Vepdegestrant (ARV-471) in I-SPY-2 Endocrine Optimization Platform (EOP) Clinical Trial PR Newswire - Tue May 2, 2023

/PRNewswire/ -- Arvinas, Inc. (Nasdaq: ARVN) and Quantum Leap Healthcare Collaborative™ today announced that Arvinas' vepdegestrant (ARV-471), a novel PROTAC®...

ARVN : 25.11 (+10.67%)

Barchart Exclusives

1 AI Stock to Buy and Hold for Long-Term Growth Barchart - Thu Nov 21, 7:18PM CST
Pure Storage stands out in AI data storage, bolstered by a new partnership with CoreWeave and a solid financial track record, making it an intriguing stock for AI-focused investors Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot